Search Results 41-50 of 14944 for HCG
Find out more about feminizing hormonal treatment used to better align the body with a person's gender identity.
Thyroid storm as an early presentation of hCG-producing metastatic choriocarcinoma: a case report and review of the literature. BMJ Case Rep. 2021 Sep 27 ...
Female patients of childbearing potential must have a negative serum beta-human chorionic gonadotrophin (β-hCG) pregnancy test at screening and a negative ...
Women of childbearing potential must have a negative serum β-human chorionic gonadotropin (HCG) pregnancy test at Visit 1A and be practicing medically ...
... hCG] test with a minimum sensitivity 25 IU/L or equivalent units of B-hCG). A separate baseline assessment is required if a negative screening pregnancy test ...
... hCG test. Currently breastfeeding. Prior or ongoing clinically significant illness, medical condition, surgical history, physical finding, or laboratory ...
Biochemical evidence of progressive disease is defined as a serially rising serum tumor marker (AFP-Alpha Feto-Protein; B-HCG-beta human chorionic gonadotropin ...
HCG ≥ 50,000 MIU/mL; AFP ≥ 10,000 ng/mL. Patients who received prior radiation therapy (RT) for treatment of germ cell tumor are eligible for this study as ...
... [HCG]) within 24 hours of starting nivolumab to rule out pregnancy. A female ... All females of childbearing potential must have a blood test or urine study done ( ...
If you took birth control pills before you knew you were pregnant, the risks of birth defects are low.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.